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Abstract
Complexins (Cplxs) are small, soluble, regulatory proteins that bind reversibly to the SNARE complex and modulate synaptic
vesicle release. Cplx1 knockout mice (Cplx12/2) have the earliest known onset of ataxia seen in a mouse model, although
hitherto no histopathology has been described in these mice. Nevertheless, the profound neurological phenotype displayed
by Cplx12/2 mutants suggests that significant functional abnormalities must be present in these animals. In this study, MRI
was used to automatically detect regions where structural differences were not obvious when using a traditional
histological approach. Tensor-based morphometry of Cplx12/2 mouse brains showed selective volume loss from the
thalamus and cerebellum. Stereological analysis of Cplx12/2 and Cplx1+/+ mice brain slices confirmed the volume loss in the
thalamus as well as loss in some lobules of the cerebellum. Finally, stereology was used to show that there was loss of
cerebellar granule cells in Cplx12/2 mice when compared to Cplx1+/+ animals. Our study is the first to describe pathological
changes in Cplx12/2 mouse brain. We suggest that the ataxia in Cplx12/2mice is likely to be due to pathological changes in
both cerebellum and thalamus. Reduced levels of Cplx proteins have been reported in brains of patients with
neurodegenerative diseases. Therefore, understanding the effects of Cplx depletion in brains from Cplx12/2 mice may also
shed light on the mechanisms underlying pathophysiology in disorders in which loss of Cplx1 occurs.
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Introduction
Complexins (Cplxs) are small, soluble, regulatory proteins [1]
that bind reversibly to the SNARE complex, playing an important
role in the modulation of neurotransmitter release [2], [3] [4] [5]
and [6]. Recently, these proteins have been shown to have a dual
function, both suppressing tonic vesicle release and promoting
stimulus-evoked release [7]. This dichotomy is achieved by the
specific binding of different domains of the protein to different
regions of the SNARE complex [8] [9] and [10].
Four different Cplx isoforms have been identified so far [1]. The
two major brain isoforms, Cplx1 and Cplx2 [2], are highly
homologous in mammals [11] and [1]. In the brain, all neurons
express one or other isoform of Cplx, furthermore Cplx1/Cplx2
double knockout mice die at birth, suggesting that Cplxs play an
essential role in the brain. Morphological studies showed that
Cplx1 and Cplx2 are present in neuronal cell bodies, processes,
and synapses [1] and [12]. In the mouse brain Cplx1 and Cplx2
have a largely reciprocal expression [13] and [14] and have been
reported to be selectively enriched in GABAergic terminals and
glutamatergic terminals respectively in the cerebellum [15] and
[12].
Despite the wide interest in the molecular actions of Cplxs, the
importance of different isoforms in the physiology of brain
function is unclear. Mice with a single isoform knocked out show
very different phenotypes from each other. In particular, Cplx1
knockout (Cplx12/2) mice have a pronounced ataxia [16], [17]
and [18] whereas Cplx22/2 mice have subtle progressive deficits in
motor, cognitive and social behaviours [16] and [19]. In Cplx12/2
mouse synapses there is a decrease of neurotransmitter release [2],
although another study suggests that there is likely to be an
optimal amount of Cplx in the synapse, since the overexpression of
Cplx2 also inhibits neurotransmitter release from normal PC12
cells [20]. In addition to abnormal phenotypes of Cplx12/2 mice,
there is indirect evidence showing that abnormal Cplx distribution
or expression is present in a number of neurological diseases.
Abnormal Cplx expression patterns have been found in patients
and animal models of psychiatric and neurodegenerative disor-
ders, such as Huntington’s Disease (HD) [21], schizophrenia [22],
[23] and [24], depression [22], [25] and [26], bipolar and unipolar
disorder [27], [28], [29] and [30], Alzheimer’s disease [31],
Parkinson’s disease [32], foetal alcohol syndrome [33] and [34],
alcoholism [35] and [34] and traumatic brain injury [36].
The dominant phenotype in Cplx12/2 mice is a severe ataxia,
which is present by 2 weeks of age [2]. These mice also have
profound exploratory and emotional deficits [17] and [37]. In
humans, ataxia is known to be associated with disturbances
affecting the cerebellar output either via abnormalities in the
cerebellar circuitry or in any of the constituent neurons or cells in
those circuits [38], [39], [40] and [41]. The majority of mouse
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models of ataxia (reviewed in [42], [43] and [44] exhibit profound
cerebellar degeneration. In contrast, the ataxia of Cplx12/2 mice
has been reported in the absence of degeneration [2] and [11].
We have recently used whole brain automated morphometry
based on MRI in a mouse model of HD (R6/2 line) to reveal a
number of changes in the R6/2 mouse brain that were not
apparent from using manual morphometry [45] and [46].
Therefore, we decided to use this method to investigate differences
in the brains of Cplx12/2 mice. We found a number of significant
differences in brain volume. We investigated those most likely to
be related to the behavioural phenotype in greater detail, using
stereological analysis with histology.
Results
MRI predicts an increased probability of atrophy of the
thalamus and cerebellum and hypertrophy of white
matter and neostriatum in Cplx12/2 mice
There was no difference in overall brain volume between
Cplx12/2 and Cplx1+/+ mice as measured by total intracranial
volume (Cplx12/2 488616 mm3, Cplx1+/+ 491614 mm3). How-
ever, comparison of the MRI sections themselves revealed a
number of clear differences between the brains (Fig. 1). Note that,
in this figure, the two brains have been rigidly aligned without
changing the size of any structure, to facilitate visual inspection.
Cplx12/2 mice appear to have thickened white matter structures
including the corpus callosum and the internal capsule and the
olfactory bulbs appear to be smaller (Fig. 1). In the cerebellum,
some of the lobes also appear to be smaller.
TBM of the MRI revealed areas of statistically significant
volume differences between some regions in Cplx12/2 and
Cplx1+/+ brains. There was an increased volume of the central
white matter including the corpus callosum, internal capsule,
cerebral peduncles and external capsule, particularly the lateral
aspects bordering the hippocampal formation. TBM of MRI also
revealed a reduction in grey matter volume in the olfactory bulbs,
the thalamus and cerebellum (Fig. 2). In the thalamus, the volume
loss was particularly clear in the ventrolateral and centromedial
nuclei, namely the centrolateral nucleus (CL), the central medial
nucleus (CM), the lateral posterior nucleus (LP), posterior thalamic
nuclear group (Po) and the paracentral (PC) and oval paracentral
nuclei (OPC) (Fig. 3). The atrophy of the cerebellum also appears
to be selective, particularly affecting lobes VI (simple lobule, Crus1
ansiform lobule), VII (Crus2 ansiform lobule) and IX. A full table
of findings from the TBM analysis is given in a table as Table S1.
Stereology shows no change in volume of caudate
putamen and corpus callosum but confirms a decrease in
thalamic and cerebellar volumes in Cplx12/2 mice
Volumes were estimated using stereology for Cplx12/2 and
Cplx1+/+ mice at two age points, one ‘early’ the other ‘late’. The
histology-based estimates did not show any significant difference
between the volume of the corpus callosum and the caudate
putamen at either early or late stages (Fig. 4C, 4D). (Note that the
lack of significance was not unexpected in the corpus callosum,
given that central white matter structures in the brain are not well
suited to volume measurements in techniques requiring serial
sectioning.) In contrast, the volume of the cerebellum and
thalamus was significantly smaller in the Cplx12/2 animals when
compared to the Cplx1+/+ at both ages (Fig. 4A, 4B). No significant
changes in volume were seen between mice killed at the early and
late stages. This suggests that, as with the behavioural phenotype,
the pathological phenotype is non-progressive. Similarly, no
significant differences in volume were observed between the
Cplx1+/+ early and late mice, suggesting that no age-dependent
brain volume changes occur in Cplx1+/+ animals over this period.
Region specific atrophy in the cerebellum of Cplx12/2
mice
Since both our TBM and stereological data supported the idea
that there was a decrease in the volume of cerebellum, and this
was likely to be relevant to the ataxic phenotype of the mice, a
more detailed study was conducted in this region. No significant
differences between genotype or age were observed in the volume
of cerebellar lobules I/II, VIII or X (Fig. 5A, 5B and 5C). By
contrast, a clear difference was observed in lobules III (Fig. 5D),
VI/VII (Fig. 5E) and IX (Fig. 5G) with volumes of Cplx12/2 mice
being significantly smaller than those of Cplx1+/+ mice, both at an
early and a late stage. A similar trend was observed for lobule IV/
Figure 1. MRI reveals volume changes between Cplx12/2 and Cplx1+/+ mice. Coronal (A, B), horizontal (D, E) and sagittal (E, F) MR images of
Cplx12/2 and Cplx1+/+ mouse brains. Volume changes can be seen in the corpus callosum (Cc), the olfactory bulbs are smaller (OB), internal capsule
(Ic) and cerebellum (CB).
doi:10.1371/journal.pone.0032636.g001
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V, but only the late time point reached statistical difference
(p,0.05) (Fig. 5F). Thus, using stereology, we confirmed that
Cplx12/2 mice have a reduced cerebellar volume in some of its
individual lobules. To investigate the cause of these differences in
Cplx12/2 mice, a more detailed histological study in lobules III,
IV/V, VI/VII and IX was conducted.
Atrophy of the molecular layer and neuron loss in the
granule layer in the cerebellum of Cplx12/2 mice
Cplx1 expression in the cerebellar cortex was found in both cells
and terminals of the Purkinje cell layer and stellate and basket cells
of the molecular layer [47]. To determine whether the selective
volume loss observed in the cerebellum of Cplx12/2 mice was due
to the atrophy of the molecular layer, volume measurements were
performed for those lobules that previously displayed a signifi-
cantly reduced volume in Cplx12/2 animals, i.e. lobules III, IV/V,
VI/VII and IX. We chose to analyse volume rather than thickness
of the layer because of the great variability in the shape of the
lobules, which might have an impact on accuracy, reliability and
significance of this measure. Small but significant differences in the
volume of molecular layer were found for all lobules studied (III,
IV/V, VI/VII, IX); (Fig. 6A).
The reduction of molecular layer thickness might be indicative
of neurodegeneration. Therefore, we decided to document the
extent of neuronal loss in those lobules, using unbiased stereology.
Although it seemed intuitively that atrophy of the molecular layer
was due to cell loss, no significant loss of neurons was evident in
the molecular layer of lobule III (Fig. 6B), IV/V, VI/VII and IX
(data not shown) in late stage Cplx12/2 and Cplx1+/+ mice.
However, the molecular layer contains relatively few neurons and
consists mainly of neuropil including extensions of apical dendritic
tufts of pyramidal neurons and horizontally-oriented axons from
granule cells, as well as glial cells [48]. To investigate the possibility
that neuropil loss might be due to loss of axons/processes from
granule cells, we used unbiased stereology to examine the number
of cells in the granule cell layer in atrophic cerebellar lobules.
Significant loss of granule neurons was found in lobules III, IV/V,
VI/VII and IX (Fig. 6B) in late Cplx12/2 mice when compared to
Cplx1+/+ mice. We also quantified neuronal numbers in a lobule
that did not reveal volume changes (lobule VIII). We found no
significant difference in neuron numbers in this lobule between
Cplx12/2 and Cplx1+/+ mice (Fig. 6B).
Discussion
When Cplx12/2 mice were first described by Reim et al. [2], no
significant macroscopic changes in the structure of their brains, the
distribution of synaptic markers or levels of other synaptic proteins
were reported. We have also never seen abnormalities in
macroscopic brains structure or distribution of neuronal markers
(e.g. calcium binding proteins) that suggest otherwise (AJM
unpublished data). Nevertheless, the profound neurological
phenotype displayed by these mutants suggests that significant
functional abnormalities must be present in these animals. Here
we used, MRI with TBM, an approach that has proved useful in
automatically detecting regions where structural abnormalities
exist [49]. We show for the first time that the volume of thalamus
and cerebellum was significantly smaller in Cplx12/2 animals
when compared to controls. It would have been impracticable to
look for small anatomical abnormalities by assessing every area of
the brain using a traditional histological approach. However we
were able to show that the reduced volume of the cerebellum and
thalamus in Cplx12/2 mice found using MRI was confirmed
through finer resolution analysis using unbiased stereology.
Having also used TBM to good effect in picking up abnormalities
in the R6/2 mouse model of Huntington’s disease [45] and [46],
we suggest that TBM of MRI is a powerful tool that allows the
detection of small anatomical changes in brains that do not appear
anatomically abnormal.
Figure 2. Tensor-based morphometry analysis of the volume changes between Cplx12/2 and Cplx1+/+ mice. Coronal sections showing
heat maps with significant volume differences between the Cplx12/2 and Cplx1+/+ brains. The scale bar shows the significant level (t-score 26 degrees
of freedom). To indicate the directionality of the tests for ease of interpretation, a separate colour mapping is used for areas of apparent atrophy (red
colour scale) vs. hypertrophy (blue colour scale).
doi:10.1371/journal.pone.0032636.g002
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In this article, we focus our discussion on the changes affecting
the grey matter. However, the white matter differences shown here
by the TBM suggest that further studies using diffusion tensor
imaging (DTI) would be appropriate, since DTI can be used for
probing structural integrity of white matter fibres in vivo [50] and
has proved a sensitive marker in a range of conditions [51].
The appearance of a decreased volume in specific brain
regions of the Cplx12/2 animals at the early stage and its non-
progressive nature suggests that the loss of Cplx1 affects the early
development of these animals.Cplx12/2 mice present with a very
early motor phenotype (ataxia from postnatal day 7; [19]). In the
cerebellum, granule cell proliferation and migration [52] and [53]
as well as growth of cerebellar afferents both occur during early
post-natal development [54] and [55], with neurons in the
cerebellum reaching their final position at approximately
postnatal day 15 in mice [56]. There is some evidence that
modulation of circuit formation [57], [58] and [59] and
cytodifferenciation [60] in the brain is controlled by neurotrans-
mitter release during development. Since a decrease of neuro-
transmitter release has been found in Cplx12/2 mice [2], it is
therefore possible that early developmental abnormalities could
occur due to abnormalities in neurotransmitter release that leads
to a dysgenesis of the cerebellum. Further studies will be needed
to determine the precise cause of the pathological abnormalities
described here.
High levels of Cplx1 are expressed in both thalamus and
cerebellum [14] and [47]. Although we did not focus on the
thalamus in the detailed histological analysis, our MRI results
show that show that the thalamic volume changes in Cplx12/2
mice affect specific nuclei. This is interesting, given that the
thalamus is a routeing station for all incoming sensory impulses,
and that each thalamic nucleus is specific for the type of
information it receives [61]. Some of the thalamic nuclei showing
atrophy are important for relaying modalities that are impaired in
Cplx12/2 mice. For example, the centrolateral nucleus, lateral
posterior nucleus and the posterior thalamic nuclei group, all relay
motor information [62] and [63], and motor coordination is
severely impaired in Cplx12/2 mice. Interestingly however, some
thalamic nuclei showing atrophy are important for relaying
modalities that have not been examined in Cplx12/2 mice. For
example, the centrolateral nucleus relays noxious visceral
information [64], and the central medial nucleus is involved in
nociception [65], [66] and [67] as well as seizure activity [68] and
[69]. The paracentral and oval paracentral nuclei, are involved in
nociceptive processing related to the affective and motivational
aspects of pain [65], [66] and [67]. It would be interesting to see if
Figure 3. Atrophy in the cerebellum and thalamus in Cplx12/2 mice. 3D reconstruction maps of tensor-based morphometry showing the
regions of atrophy (red) in the cerebellum (A) and thalamus (D), and 2D cartoons showing coronal sections of the cerebellum (B, C) and thalamus (E)
showing the same regions of atrophy (grey). (Sim) simple lobule, (Crus1) Crus1 of the ansiform lobule, (Crus2) Crus2 of the ansiform lobule, (VI) lobule
VI, (IX) lobule IX, (CL) centrolateral nucleus, (CM) central medial nucleus, (LPLR) lateral posterior nucleus laterorostral, (LPMR) lateral posterior nucleus
mediorostral, (Po) posterior thalamic nuclear group, (PC) paracentral nucleus and (OPC) oval paracentral nucleus.
doi:10.1371/journal.pone.0032636.g003
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Cplx12/2 mice have deficits relating to abnormal processing of
those modalities.
It is well known that the cerebellum plays a major role in motor
coordination and the fine adjustment of movements (for review see
[70]), and abnormalities in cerebellar development and/or
function often result in a typical uncoordinated phenotype in
mice (for review see [71]). In addition, previous studies have shown
cerebellar atrophy in other mouse models of ataxia [72], [73] and
[71]. Therefore, although pathological abnormalities in the
cerebellum have not been reported in Cplx12/2 mice previously,
it was not surprising to find significant volume loss in the
cerebellum of these mice. However, it was interesting that the
volume loss in the cerebellum was not generalized but rather that
lobes were differentially affected, with some lobes apparently
spared in Cplx12/2 mice. Although the division of the cerebellum
into lobules is based on anatomical distinctions, and as yet no
specific functions have been attributed unequivocally to each of
the lobules, some of them are very well known for being involved
in specific functions. For example, in cats lobules VI–VII
denominated the ‘‘oculomotor vermis’’ are important in the
control of eye movements [74]. A topographic organization of
motor control and cognitive and emotional processing in the
cerebellum has also been hypothesized [75]. As well, the role of the
cerebellum in human cognition has been the focus of recent
reviews [76], [77]. According to this hypothesis, the anterior lobe
of the cerebellum (lobules I–V) plus parts of lobule VI and Lobule
VIII constitute the sensorimotor cerebellum, while lobule VIII and
parts of lobule VI form the cognitive cerebellum. Therefore,
changes in the volumes of lobules III and IV/V, which are
involved in motor control, may contribute to the motor phenotype
seen in Cplx12/2 mice, while the sensory [78] and social [17]
deficits seen in these animals may be due to changes in lobules VI/
VII, that we have shown to be smaller in the Cplx12/2 mice.
Detailed analysis of volume loss in the cerebellum revealed a
significant loss of granule cells, as well as a reduction in molecular
layer volume. The reduced volume of the molecular layer was not
due to reduced number of cells but was likely to be due to a loss of
processes from granule cells that send processes in the molecular
layer [79]. A loss or degeneration of these processes could directly
induce granule cell degeneration. As said previously, it is not clear
if the cell loss in Cplx12/2 mice is due to developmental
abnormalities or neurodegenerative processes; either of these is
possible. Since Cplxs are centrally important for controlling Ca2+-
triggered exocytosis [80], a depletion of Cplxs will have deletrious
Figure 4. Region-specific atrophy in the Cplx12/2 mouse brain. Volumes of thalamus (A), cerebellum (B) caudate putamen (C) and corpus
callosum (D) were measured at early and late stages in Cplx1+/+ (open columns) and Cplx12/2 mice (closed columns). (* p,0.05; ** p,0.01;
*** p,0.001, all columns show means 6SEM).
doi:10.1371/journal.pone.0032636.g004
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effects on synaptic transmission and neurons lacking Cplxs show
dramatically reduced transmitter release efficiency due to
decreased Ca2+ sensitivity of the synaptic secretion process [2].
Reduced neurotransmitter release can cause mal-formation, or no
formation at all, of synapses during development [58] and [59]. A
similar phenomenon might cause a reduced neuron number in
Cplx12/2 mice. It is also possible that a reduced cell number in
Cplx12/2 mice could be due to excitotoxicity caused by a lack of
GABAergic inhibition. Indeed, although it is not the case in all
parts of the brain, in the cerebellum, Cplx1 is selectively expressed
in inhibitory neurons [12]. Loss of Cplx1 would lead to a decrease
in inhibition and could result in an increased activity of granule
cells and could lead to cell death via excitotoxic mechanisms. A
loss of granule cells due to the increased glutamate transmission
observed in the Purkinje cell/parallel fibre synapse has been found
in several mouse models of ataxia [81], [82] and [83]. In addition
to granule cells, the granule layer is also composed of Golgi cells,
which provide an inhibitory feedback to the granule cells [79]. A
decrease in inhibitory pathways could again lead to excitotoxic
damage. Loss of both granule and Golgi cells has been observed in
the ‘leaner’ mutant mouse, which displays severe ataxia and cell
loss in the cerebellar cortex [84]. In summary, dysgenesis and
neurodegeneration are two possible outcomes of Cplx1 deficiency
that results in ataxia in Cplx12/2 mice. For example, in the
Weaver mouse model granule cells cannot migrate and differen-
tiate into the granule layer [85], whereas the SCA1 and SCA2
mouse models display pure neurodegeneration [86] and [87].
However, no studies have been conducted in Cplx12/2 mice at
embryonic stages and we cannot be certain as to which mechanism
is involved in the pathology in those mice.
It is well documented that the majority of ataxias (for review see
[88]) as well as patients with Wernicke-Korsakoff syndrome [89]
show cerebellar atrophy. The involvement of the thalamus has also
been reported previously in patients with spinocerebellar ataxias
Figure 5. Atrophy occurs in specific cerebellar lobules in Cplx12/2mice. Volumes of lobules I/II (A), VIII (B), X (C), IV/V (D), IX (E), III (F) and VI/
VII (G) were measured at early and late stages in Cplx1+/+ (open columns) and Cplx12/2 mice (closed columns). (* p,0.05; ** p,0.01; *** p,0.001, all
columns show means 6SEM).
doi:10.1371/journal.pone.0032636.g005
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type 2, 3 and 7 [90], [91], [92] and [93], autosomal recessive ataxia
[94] and patients with Wernicke-Korsakoff syndrome [89]. In
addition, loss of granule cells in the cerebellum has been previously
reported in siblings with ataxia-telangiectasia-like disorder [95] as
well as in mouse models of ataxia [84], [82] and [83]. Although the
relationship between Cplx1 and ataxia is not known [2] and [11],
the high levels of Cplx1 expression in the cerebellum and thalamus
[14], the reduced volume of these regions in Cplx12/2 mice
reported here and the involvement of the cerebellum and thalamus
in movement control seem to indicate that both these regions might
be involved in the development of the abnormal motor function that
is a result of Cplx1 depletion in mice.
Our study is the first to describe pathological changes in the
cerebellum and the thalamus of the Cplx12/2 mouse brain. The
cerebellar and thalamic regions that show atrophy in Cplx12/2mice
are important for motor as well as cognitive processing. Therefore, it
seems likely that pathology in these regions contributes to ataxia and
possibly other phenotypic abnormalities observed in the Cplx12/2
mouse. Our current understanding of the role of changes in Cplxs in
neurodegenerative diseases is poor. A better understanding the
effects of Cplx depletion in the brain may shed light on its role, not
only in the normal brain but also in the mechanisms underlying
pathophysiology in ataxias and neurodegenerative disorders in
which loss of Cplxs occurs.
Methods
Animals
Cplx1 mice were generated by homologous recombination in
embryonic stem cells [2]. All Cplx12/2 mice used in this study
were F1 or F2 mice bred from heterozygote mice on a mixed
genetic background (129Ola/C57Bl6) in a colony established in
the Department of Pharmacology, University of Cambridge.
Cplx1 mice have since been backcrossed onto a C57/Bl6 inbred
background for 10 generations, without change in the overt
phenotype (unpublished observations). All experimental proce-
dures were licensed and undertaken in accordance with the
regulations of the UK Animals (Scientific Procedures) Act 1986.
Figure 6. Decrease in volume of molecular layer and neuron loss in the granule layer in cerebellar lobules III, IV/V, VI/VII, VIII and IX
in Cplx12/2 mice. Volumes of lobules III, IV/V, VI/VII IX and VIII (A) were measured at late stage in Cplx1+/+ and Cplx12/2 mice. Numbers of Nissl
stained granule cells in cerebellar lobules III, IV/V, VI/VII, IX and VIII were measured at late stage in Cplx1+/+ and Cplx12/2 mice (B). (* p,0.05;
** p,0.01; *** p,0.001, NS not significant, all columns show means 6SEM).
doi:10.1371/journal.pone.0032636.g006
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For MRI, thirty adult mice were used; n = 12 Cplx1+/+ (age
range 50–52 mean 51 weeks) and n= 18 Cplx12/2 (age range 34–
78 mean 59 weeks). The brains of R6/2 mice were scanned ex vivo
because their health status did not allow the study to be done in
vivo. Animals were deeply anaesthetized with Avertin (10 ml/kg
i.p.) and perfusion fixed. Brains were not removed from the skull in
order to preserve overall brain shape and to avoid damage to
structures adjacent to the pial surface. Specimens were stored in
4% paraformaldehyde solution under refrigeration until they were
imaged.
For stereological volume measurements another cohort of mice
was used. Brains from an ‘early’ (aged between 4 and 10 weeks)
and a ‘late’ (.2 years of age), group of Cplx12/2 mice and age-
matched littermate controls were harvested. In Cplx12/2 mice the
ataxic gait is apparent by postnatal day 7 (P7) and is pronounced
by the time of weaning (21 days) [17], therefore it is important to
note that both ‘early’ and ‘late’ groups of animals are
symptomatic. Mice were killed for histology by asphyxiation with
rising levels of CO2 (n= 4 at each age and genotype). Brains were
removed and immediately frozen on dry ice. For stereological
neuron quantifications, an additional ‘late’ group (n= 3) of
Cplx12/2 mice and age-matched littermate controls were perfused
transcardially with 4% paraformaldehyde in 0.1 M phosphate-
buffered saline (PBS) and immersion fixed for at least 1 week in
4% paraformaldehyde. All brains were subsequently cryoprotected
in a solution of 30% sucrose in PBS until required.
Animal husbandry. All mice were housed in hard-bottomed
polypropylene experimental cages in groups of 10–16 mice.
Lighting was controlled on a 12 h light: 12 h dark cycle. The
housing facility temperature was maintained at 21–23uC and the
relative humidity was also controlled (55610%). Clean cages were
provided twice weekly with corncob bedding and fine shredded
paper nesting material. The mice had ad libitum access to water and
standard dry laboratory food. As Cplx12/2 mice have difficulty in
balance rearing, all Cplx12/2 mice were provided with lowered
waterspouts and twice daily supplementary feeding. Supplementary
feeding consisted of softened chow pellets placed on the floor of the
home cage twice daily.
Genotyping. Genotyping was done using DNA prepared
from tail biopsies and carried out using a polymerase chain
reaction (PCR) as described previously [17].
MRI
To assess the morphological phenotype of Cplx12/2 mouse
brains, we imaged the brains using high-resolution MR micros-
copy and used tensor-based morphometry (TBM), a method that
localizes differences in the local shape of brain structures, to
evaluate the differences between genotypes [49].
Immediately prior to imaging, specimens were immersed in
Fluorinert FC-70 (3 M, Inc.), a proton-free susceptibility-matching
fluid to reduce wraparound artefacts due to fixation fluid whilst
preventing artefacts due to the magnetic field inhomogeneities due
to air boundaries close to the brain. Imaging was performed using
a Bruker PharmaScan 4.7 T system with a 20 mm birdcage
resonator for sample excitation and signal reception.
A rapid acquisition with relaxation enhancement (RARE)
sequence was used (repetition time (TR)/echo time (TE) 2000/
32 ms, echo train length (ETL) 8, number of excitations (NEX) 2),
with matrix 25661926128 over field of view 17.9613.469.0 mm3
yielding an isotropic resolution of 70 mm in a scan time of 3.5 h).
These parameters were chosen to optimise contrast between grey
and white matter in the brain.
Images were processed using SPM5 (Wellcome Trust Centre for
Neuroimaging, UCL) [96] with the SPM Mouse toolbox [45] and
[46] (http://www.wbic.cam.ac.uk/,sjs80/spmmouse.html). Brains
were manually adjusted for approximate alignment with the tissue
probability maps from our previous studies of the mouse brain [45]
and [46]. Unified segmentation [96] was used to perform affine
registration, bias correction and non-linear registration to bring the
brains into the same stereotactic space and produce maps of grey
matter and white matter.
These maps were used with DARTEL [97], a diffeomorphic
registration algorithm to accurately register the brains. The
Jacobian determinants at each voxel within the brain were
calculated using the deformation fields from the DARTEL
algorithm and smoothed using an isotropic Gaussian kernel of
400 mm. To compare whole brain volumes, the total amounts of
GM, WM and fluid in the brain from the segmented tissue maps
were summed to give total intracranial volume for each specimen.
Stereology
Serial sections (30 or 50 mm) were cut serially through the whole
brain of each mouse, making sagittal sections of the cerebellum
and coronal sections of the rest of the brain. The sections were
then mounted onto gelatinised slides in order to be processed for
histochemical staining. Slides were subsequently stained with
Cresyl violet (Sigma Chemical Company, Dorset, UK). Slides
were defatted in Histoclear (Cellpath, Powys, Mid Wales, UK) for
3 min, followed by dehydration for 2 min each in absolute ethanol
and 95% ethanol, and 1 min in 70% ethanol. The sections were
then washed with clean tap water for 30–60 s. After soaking in 1%
Cresyl violet for 15 min, slides were again washed with tap water
for 30–60 s until the water ran clear. They were then
differentiated for 10 s in 1% acetic acid/alcohol and washed in
distilled water. After 1 min in 70% ethanol, slides were placed for
2 min in each of 95% then absolute ethanol twice. Samples were
placed in three successive pots of Histoclear for 1, 3 and 3 min,
respectively, and coverslipped with DPX mounting medium
(BDH, Lutterworth, Leicestershire, UK). After mounting the
slides were dried in an oven at 37uC for at least 24 hours.
Unbiased Cavalieri estimates of the volume [98] of the caudate
putamen, corpus callosum, thalamus, cerebellum, cerebellar
lobules and cerebellar layers were made on Nissl stained sections
using a Nikon Eclipse 80i microscope and StereoInvestigator
software (Micro-brightfield Inc., Williston, VT, USA), with the
operator blind to genotype. An appropriately spaced sampling grid
(250 mm thalamus; 200 mm caudate putamen and cerebellum;
125 mm corpus callosum and cerebellar lobules IV/V and VI/VII;
100 mm cerebellar lobules I/II, III, VII and IX; 75 mm cerebellar
lobule X; 50 mm cerebellar molecular layer) was superimposed
over the sections and the number of points covering the relevant
areas counted using an62 objective. Regional volumes expressed
in mm3 were collected for each animal and the mean volume of
each region obtained for Cplx1+/+ and Cplx12/2 mice. The
delineation of each region was consistently performed by referring
to the Paxinos and Franklin Mouse Brain Atlas (2004) [99].
To examine neuronal survival within the molecular layer of
individual cerebellar lobules we used StereoInvestigator software to
obtain unbiased optical fractionator estimates of neuronal
numbers in Nissl stained sections. These estimates were obtained
for lobules III and VIII. These measures were performed with a
random starting section chosen, followed by every fifth Nissl
stained section thereafter. For lobule III, the counting frame size
was 20 mm620 mm and the grid size used was 150 mm6120 mm.
For lobule IV/V, the counting frame size was 20 mm620 mm and
the grid size used was 200 mm6120 mm. For lobule IX, the
counting frame size was 20 mm620 mm and the grid size used was
150 mm6120 mm. Finally, for lobule VI/VII, the counting frame
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size was 20 mm620 mm and the grid size used was 200 mm6
150 mm.
Statistical Analysis
For MRI, measures of total intracranial volume (mean 6 SD)
were compared with a two-tailed Student’s t-test with P,0.05 used
as a threshold for statistical significance. A general linear model
was fitted to the smoothed Jacobian determinant values at each
voxel for genotype with sex and overall brain volume as covariates.
The effect of genotype was assessed at each voxel as a two-sample
Student’s t-test. To control for multiple comparisons, the false-
discovery rate (FDR) was controlled at q,0.01 [100]. With this
correction one would expect, on average, that 1% of the results
reported to be significant are in fact false positives. In addition to
this, a cluster-extent threshold was applied, ignoring all clusters
with a total number of voxels fewer than 500.
For stereology, a two-way ANOVA was used to analyze all the
volume and quantifications data (mean 6 SEM) with a post-hoc
Bonferroni test. P,0.05 was considered as statistically significant.
For all optical fractionator estimates, the mean coefficient of error
of individual estimates was calculated according to the method of
Gundersen and Jensen [99] and was ,0.05 in all analyses.
Supporting Information
Table S1 Significant regions found in the TBM analysis
between Cplx1+/+ and Cplx12/2 mice. Structures are
reported at the centre of each cluster, which may extend into
surrounding areas within and around the region denoted as the
major structure (p,0.01 FDR-corrected, cluster extent greater
500 only). Coordinates are given relative to bregma (left–right,
anterior-posterior and inferior-superior respectively).
(DOC)
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